A consortium including Indian agchem producer UPL in exclusive talks with Platform Specialty for Arysta: Bloomberg
Jun. 22, 2018
UPL is teaming up with sovereign wealth fund Abu Dhabi Investment Authority and other investors for PAH's Arysta LifeScience, according to the report.
PAH, whose biggest stakeholder is Bill Ackman’s Pershing Square Capital Management, said yesterday it had entered exclusive talks on a potential sale of Arysta but did not identify the suitor.
PAH has been in talks with several suitors, including U.K. investment vehicle Wilmcote Holdings, about a potential deal but Wilmcote says talks between the companies have ended.
Platform CEO Rakesh Sachdev said, “As we commented on June 7, 2018, in pursuing a separation of our businesses into two standalone companies we have had discussions with several parties regarding an acquisition of or investment in Arysta LifeScience. We are now in exclusive discussions with a potential acquirer of the business and expect to have more information to provide to our shareholders and all our stakeholders on or before our second quarter earnings conference call. As we have repeatedly emphasized, we will choose the path for our separation that we believe creates an optimal outcome for our shareholders, and we will keep all of our stakeholders apprised as and when appropriate.”
More from AgroNews
- Top 20 Brazilian agrochem companies in 2017: Mergers will increase market concentration in the future
- Sichuan Lomon Bio Takes S-ABA and Gibberellin as Core Products to Build Full Range Product Line on Basis of Biotechnology
- AkzoNobel Specialty Chemicals rebrands as Nouryon
- What venture capital looks for in agricultural start-ups